23 February 2009 Study of false positives in 5-ALA induced photodynamic diagnosis of bladder carcinoma
Author Affiliations +
Abstract
Photodynamic diagnosis (PDD) is a technique that enhances the detection of tumors during cystoscopy using a photosensitizer which accumulates primarily in cancerous cells and will fluoresce when illuminated by violetblue light. A disadvantage of PDD is the relatively low specificity. In this retrospective study we aimed to identify predictors for false positive findings in PDD. Factors such as gender, age, recent transurethral resection of bladder tumors (TURBT), previous intravesical therapy (IVT) and urinary tract infections (UTIs) were examined for association with the false positive rates in a multivariate analysis. Data of 366 procedures and 200 patients were collected. Patients were instilled with 5-aminolevulinic acid (5-ALA) intravesically and 1253 biopsies were taken from tumors and suspicious lesions. Female gender and TURBT are independent predictors of false positives in PDD. However, previous intravesical therapy with Bacille Calmette-Guérin is also an important predictor of false positives. The false positive rate decreases during the first 9-12 weeks after the latest TURBT and the latest intravesical chemotherapy. Although shortly after IVT and TURBT false positives increase, PDD improves the diagnostic sensitivity and results in more adequate treatment strategies in a significant number of patients.
© (2009) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Ronald O. P. Draga, Ronald O. P. Draga, Matthijs C. M. Grimbergen, Matthijs C. M. Grimbergen, Esther T. Kok, Esther T. Kok, Trudy G. N. Jonges, Trudy G. N. Jonges, J. L. H. Ruud Bosch, J. L. H. Ruud Bosch, } "Study of false positives in 5-ALA induced photodynamic diagnosis of bladder carcinoma", Proc. SPIE 7161, Photonic Therapeutics and Diagnostics V, 71611Q (23 February 2009); doi: 10.1117/12.807806; https://doi.org/10.1117/12.807806
PROCEEDINGS
11 PAGES


SHARE
Back to Top